There is no consensus on the choice of drug treatment for refractory generalized convulsive status epilepticus in children. The objective of this meta-analysis of the published literature was to determine the effects of drug treatments on efficacy (seizure cessation) and mortality in children with this condition, controlling for potential confounding factors. One hundred eleven children, treated with diazepam, midazolam, thiopental, pentobarbital, or isoflurane, met strict inclusion criteria. Diazepam was significantly less efficacious than other treatments (P = .006) stratifying for etiology. Overall mortality was 20% in symptomatic cases and 4% in idiopathic cases (P = .038). Mortality was less frequent in midazolam-treated patients (P = .021) stratifying for etiology. Midazolam appears to be a good choice for initial treatment of refractory generalized convulsive status epilepticus in children, but the attribution of differences in efficacy and mortality solely to drug effect is not possible based on the published literature. (J Child Neurol 1999;14:602-609).
Get full access to this article
View all access options for this article.
References
1.
Anonymous: Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America's Working Group on Status Epilepticus, comments. JAMA1993;270:854-859.
2.
Singhi S., Banerjee S., Singhi P.: Refractory status epilepticus in children: Role of continuous diazepam infusion . J Child Neurol1998; 13:23-26.
3.
Bertz RJ, Howrie DL: Diazepam by continuous intravenous infusion for status epilepticus in anticonvulsant hypersensitivity syndrome. Ann Pharmacother1993;27:298-301.
4.
Goitein KJ, Mussaffi H., Melamed E.: Treatment of status epilepticus with thiopentone sodium anaesthesia in a child . Eur J Pediatr1983;140:133-135.
5.
Kofke WA, Young RS, Davis P., et al: Isoflurane for refractory status epilepticus: A clinical series. Anesthesiology1989;71:653-659.
6.
Crawford TO, Mitchell WG, Snodgrass SR: Lorazepam in childhood status epilepticus and serial seizures: Effectiveness and tachyphylaxis. Neurology1987;37:190-195.
7.
Kumar A., Bleck TP: Intravenous midazolam for the treatment of refractory status epilepticus. Crit Care Med1992;20:483-488.
8.
Lal Koul R., Raj AG, Chacko A., et al: Continuous midazolam infusion as treatment of status epilepticus . Arch Dis Child1997;76: 445-448.
9.
Parent JM, Lowenstein DH: Treatment of refractory generalized status epilepticus with continuous infusion of midazolam. Neurology1994;44:1837-1840.
10.
Rivera R., Segnini M., Baltodano A., Pérez V.: Midazolam in the treatment of status epilepticus in children, comments. Crit Care Med1993;21:991-994.
11.
Sheth RD, Buckley DJ, Gutierrez AR, et al: Midazolam in the treatment of refractory neonatal seizures. Clin Neuropharmacol1996;19:165-170.
12.
Kinoshita H. , Nakagawa E., Iwasaki Y., et al: Pentobarbital therapy for status epilepticus in children: Timing of tapering. Pediatr Neurol1995;13:164-168.
13.
Lowenstein DH, Aminoff MJ, Simon RP: Barbiturate anesthesia in the treatment of status epilepticus: Clinical experience with 14 patients. Neurology1988;38:395-400.
14.
Rashkin MC, Youngs C., Penovich P.: Pentobarbital treatment of refractory status epilepticus. Neurology1987;37:500-503.
15.
Van Ness PC: Pentobarbital and EEG burst suppression in treatment of status epilepticus refractory to benzodiazepines and phenytoin. Epilepsia1990;31:61-67.
16.
Young RS, Ropper AH, Hawkes D., et al: Pentobarbital in refractory status epilepticus. PediatrPharmacol (New York) 1983;3: 63-67.
17.
Crawford TO, Mitchell WG, Fishman LS, Snodgrass SR: Very-high-dose phenobarbital for refractory status epilepticus in children . Neurology1988;38:1035-1040.
18.
Exil G., Clancy RR, Hyder DJ: Propofol treatment of refractory status epilepticus: A report of five pediatric cases, abstract. Epilepsia1995;36:124.
19.
Eriksson KJ , Koivikko MJ: Status epilepticus in children: Aetiology, treatment, and outcome, comments. Dev Med Child Neurol1997;39:652-658.
20.
Orlowski JP , Erenberg G., Lueders H., Cruse RP: Hypothermia and barbiturate coma for refractory status epilepticus. Crit Care Med.1984;12:367-372.
21.
Tasker RC, Boyd SG, Harden A., Matthew DJ: EEG monitoring of prolonged thiopentone administration for intractable seizures and status epilepticus in infants and young children. Neuropediatrics1989;20:147-153.
22.
Lowenstein DH, Alldredge BK: Status epilepticus. N Engl J Med1998;338:970-976.
23.
Bleck TP: Advances in the management of refractory status epilepticus, editorial. Crit Care Med1993;21:955-957.
24.
Pellock JM: Use of midazolam for refractory status epilepticus in pediatric patients. J Child Neurol1998;13:581-587.
25.
Maytal J., Shinnar S., Moshé SL, Alvarez LA: Low morbidity and mortality of status epilepticus in children. Pediatrics1989;83:323-331.
26.
Verity CM, Ross EM, Golding J.: Outcome of childhood status epilepticus and lengthy febrile convulsions: Findings of national cohort study. BMJ1993;307:225-228.
27.
Labar DR, Ali A., Root J.: High-dose intravenous lorazepam for the treatment of refractory status epilepticus . Neurology1994;44: 1400-1403.
28.
Motamedi GK , Noebels JL: Management of status epilepticus. Resident Staff Physician1998;SS:S12-S19
29.
Stecker MM, Kramer TH, Raps EC, et al: Treatment of refractory status epilepticus with propofol: Clinical and pharmacokinetic findings. Epilepsia1998 ;39:18-26.
30.
Lacroix J., Deal C., Gauthier M., et al: Admissions to a pediatric intensive care unit for status epilepticus: A 10-year experience. Crit Care Med1994;22:827-832.
31.
LeLorier J. , Gregoire G., Benhaddad A., et al: Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N Engl J Med1997;337:536-542.
